Luuk van Hooren

机构：Uppsala University, Science for Life Laboratory · ORCID：0000-0002-0780-5827

发表论文 34 篇 · 总被引 991 次 · h-index 12

代表论文

• Vascular Targeting to Increase the Efficiency of Immune Checkpoint Blockade in Cancer (2018 · Frontiers in Immunology · 被引 183)
• Agonistic CD40 therapy induces tertiary lymphoid structures but impairs responses to checkpoint blockade in glioma (2021 · Nature Communications · 被引 164)
• Tailoring vascular phenotype through AAV therapy promotes anti-tumor immunity in glioma (2023 · Cancer Cell · 被引 150)
• Platelet-Specific PDGFB Ablation Impairs Tumor Vessel Integrity and Promotes Metastasis (2020 · Cancer Research · 被引 109)
• CD103+ regulatory T cells underlie resistance to radio-immunotherapy and impair CD8+ T cell activation in glioblastoma (2023 · Nature Cancer · 被引 108)
• Local checkpoint inhibition of CTLA‐4 as a monotherapy or in combination with anti‐PD1 prevents the growth of murine bladder cancer (2016 · European Journal of Immunology · 被引 80)